Jenburkt Pharmaceuticals Ltd
Jenburkt Pharmaceuticals Ltd Share Price Today: Live Updates & Key Insights
Get insights on Jenburkt Pharmaceuticals Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Jenburkt Pharmaceuticals Ltd Share Price Chart
JENBURKTPHARMA at 06 Feb 2026 02:46 PM Pharmaceuticals
1073.75 +13.20(+1.24%)
Lowest Today 1060.00
Highest Today 1073.75
Today's Open 1073.75
Prev. Close 1060.55
52 Week High 1410.00
52 Week Low 936.70
Jenburkt Pharmaceuticals Ltd Fundamentals
Traded Volume: 175
Market Cap(Cr): 474
Avg Traded Price 1061.64
1 Year return -3.20%
Upper Circuit 1,073.8
Lower Circuit 1,060
P/E TTM 0.00
P/B Ratio 2.725
Traded Value(Cr) 1.88
EPS TTM NaN
Book value/Share 389.220
Dividend Yield 1Y 0.00%
Jenburkt Pharmaceuticals Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Jenburkt Pharmaceuticals Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Jenburkt Pharmaceuticals Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W 0.00%
1M 0.00%
3M 0.00%
1Y -3.20%
YTD 0.00%
Jenburkt Pharmaceuticals Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Jenburkt Pharmaceuticals Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday N/A
Day Before Yesterday N/A
1W Avg N/A
1M Avg N/A
3M Avg N/A
Jenburkt Pharmaceuticals Ltd Technical Details
Jenburkt Pharmaceuticals Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 1045
Support 2 1030
Support 3 1009
Pivot Point : 1066
Resistance 1 1082
Resistance 2 1103
Resistance 3 1118
Jenburkt Pharmaceuticals Ltd Corporate Actions
Jenburkt Pharmaceuticals Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Jenburkt Pharmaceuticals Ltd’s capital allocation strategies.
All
Ex-Date 11-Jul-2025 Type D Description 18.00/share@180.00% Record Date 11-Jul-2025 Ratio 180.00
Ex-Date 23-Jul-2024 Type D Description 15.30/share@153.00% Record Date - Ratio 153.00
Ex-Date 19-Jul-2023 Type D Description 14.40/share@144.00% Record Date - Ratio 144.00
Ex-Date 21-Jul-2022 Type D Description 12.00/share@120.00% Record Date - Ratio 120.00
Ex-Date 30-Aug-2021 Type D Description 10.20/share@102.00% Record Date - Ratio 102.00
Ex-Date 18-Mar-2020 Type D Description 8.10/share@81.00% Record Date 19-Mar-2020 Ratio 81.00
Ex-Date 22-Jul-2019 Type D Description 10.20/share@102.00% Record Date - Ratio 102.00
Ex-Date 23-Jul-2018 Type D Description 6.00/share@60.00% Record Date - Ratio 60.00
Ex-Date 27-Mar-2018 Type D Description 3.00/share@30.00% Record Date 28-Mar-2018 Ratio 30.00
Ex-Date 09-Nov-2017 Type T Description /share@% Record Date - Ratio
Ex-Date 21-Jul-2017 Type D Description 8.10/share@81.00% Record Date - Ratio 81.00
Ex-Date 19-Jul-2016 Type D Description 0.90/share@9.00% Record Date - Ratio 9.00
Ex-Date 17-Mar-2016 Type D Description 6.30/share@63.00% Record Date 18-Mar-2016 Ratio 63.00
Ex-Date 31-Aug-2015 Type D Description 6.30/share@63.00% Record Date - Ratio 63.00
Ex-Date 03-Sep-2014 Type D Description 5.10/share@51.00% Record Date - Ratio 51.00
Ex-Date 18-Sep-2013 Type D Description 4.20/share@42.00% Record Date - Ratio 42.00
Ex-Date 23-Jul-2012 Type D Description 3.50/share@35.00% Record Date - Ratio 35.00
Ex-Date 21-Jul-2011 Type D Description 3.50/share@35.00% Record Date - Ratio 35.00
Ex-Date 21-Jul-2010 Type D Description 3.00/share@30.00% Record Date - Ratio 30.00
Ex-Date 23-Jul-2009 Type D Description 1.80/share@18.00% Record Date - Ratio 18.00
Ex-Date 23-Jul-2008 Type D Description 1.25/share@12.50% Record Date - Ratio 12.50
Ex-Date 18-Jul-2007 Type D Description 1.25/share@12.50% Record Date - Ratio 12.50
Dividends
Announcement Date 11-Jul-2025 Ex Dividend Date 11-Jul-2025 Dividend(%) 180
Announcement Date 23-Jul-2024 Ex Dividend Date 23-Jul-2024 Dividend(%) 153
Announcement Date 19-Jul-2023 Ex Dividend Date 19-Jul-2023 Dividend(%) 144
Announcement Date 21-Jul-2022 Ex Dividend Date 21-Jul-2022 Dividend(%) 120
Announcement Date 30-Aug-2021 Ex Dividend Date 30-Aug-2021 Dividend(%) 102
Announcement Date 18-Mar-2020 Ex Dividend Date 18-Mar-2020 Dividend(%) 81
Announcement Date 22-Jul-2019 Ex Dividend Date 22-Jul-2019 Dividend(%) 102
Announcement Date 23-Jul-2018 Ex Dividend Date 23-Jul-2018 Dividend(%) 60
Announcement Date 27-Mar-2018 Ex Dividend Date 27-Mar-2018 Dividend(%) 30
Announcement Date 21-Jul-2017 Ex Dividend Date 21-Jul-2017 Dividend(%) 81
Announcement Date 19-Jul-2016 Ex Dividend Date 19-Jul-2016 Dividend(%) 9
Announcement Date 17-Mar-2016 Ex Dividend Date 17-Mar-2016 Dividend(%) 63
Announcement Date 31-Aug-2015 Ex Dividend Date 31-Aug-2015 Dividend(%) 63
Announcement Date 03-Sep-2014 Ex Dividend Date 03-Sep-2014 Dividend(%) 51
Announcement Date 18-Sep-2013 Ex Dividend Date 18-Sep-2013 Dividend(%) 42
Announcement Date 23-Jul-2012 Ex Dividend Date 23-Jul-2012 Dividend(%) 35
Announcement Date 21-Jul-2011 Ex Dividend Date 21-Jul-2011 Dividend(%) 35
Announcement Date 21-Jul-2010 Ex Dividend Date 21-Jul-2010 Dividend(%) 30
Announcement Date 23-Jul-2009 Ex Dividend Date 23-Jul-2009 Dividend(%) 18
Announcement Date 23-Jul-2008 Ex Dividend Date 23-Jul-2008 Dividend(%) 13
Announcement Date 18-Jul-2007 Ex Dividend Date 18-Jul-2007 Dividend(%) 13
Bonus
No Bonus has been declared by JENBURKTPHARMA
Splits
No Split has been declared by JENBURKTPHARMA
Others
Ex-Rights Date 09-Nov-2017 Premium(Rs.) Ratio
Jenburkt Pharmaceuticals Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Jenburkt Pharmaceuticals Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Jenburkt Pharmaceuticals Ltd's relative performance and valuation against major competitors.
Stock Name Influx Healthtech Ltd ₹224.00 (+0.99%) M. Cap (Cr) 5.19 1 Yr Return (%) NaN% P/E (TTM) 38.80 PB Ratio 5.75
Stock Name Vikram Thermo (India) Ltd ₹160.00 (-0.03%) M. Cap (Cr) 5.02 1 Yr Return (%) -20.28% P/E (TTM) 15.13 PB Ratio 3.65
Stock Name Medicamen Biotech Ltd ₹351.35 (-0.38%) M. Cap (Cr) 4.77 1 Yr Return (%) -34.01% P/E (TTM) 46.92 PB Ratio 1.73
Stock Name Jenburkt Pharmaceuticals Ltd ₹1073.75 (+1.24%) M. Cap (Cr) 4.74 1 Yr Return (%) -3.20% P/E (TTM) 14.62 PB Ratio 2.59
Stock Name Amanta Healthcare Ltd ₹103.96 (-0.44%) M. Cap (Cr) 4.04 1 Yr Return (%) NaN% P/E (TTM) 30.30 PB Ratio 1.92
Stock Name Medico Remedies Ltd ₹47.90 (-0.83%) M. Cap (Cr) 3.97 1 Yr Return (%) -36.84% P/E (TTM) 35.03 PB Ratio 5.95
Stock Name Everest Organics Ltd ₹412.00 (+1.43%) M. Cap (Cr) 4.00 1 Yr Return (%) +51.33% P/E (TTM) 60.49 PB Ratio 5.52
Jenburkt Pharmaceuticals Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Jenburkt Pharmaceuticals Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2025 27.91 Mar 2024 8.12 Mar 2023 17.05 Mar 2022 9.40 Mar 2021 18.03
PARTICULARS Investing Activities Mar 2025 -17.04 Mar 2024 -0.58 Mar 2023 2.62 Mar 2022 -1.33 Mar 2021 -18.78
PARTICULARS Financing Activities Mar 2025 -7.62 Mar 2024 -7.08 Mar 2023 -21.04 Mar 2022 -5.53 Mar 2021 0.71
PARTICULARS Net Cash Flow Mar 2025 3.24 Mar 2024 0.47 Mar 2023 -1.37 Mar 2022 2.54 Mar 2021 -0.04
Jenburkt Pharmaceuticals Ltd Shareholding Pattern
This shows the ownership breakdown of Jenburkt Pharmaceuticals Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter N/A%
Public N/A%
Other Institutions N/A%
FII N/A%
Mutual Funds N/A%
About Jenburkt Pharmaceuticals Ltd
Jenburkt Pharmaceuticals Limited, incorporated in 1985, was formed a joint venture to diversify into the healthcare and pharmaceutical industry, by Bhuta family. The Company is engaged in manufacturing and marketing of speciality and high quality pharmaceutical formulations and healthcare products.Presently, the Company manufactures and markets pharmaceutical formulations in India and internationally across 13 countries. It has more than 1,000 stockists and their reach extends to 400,000+ pharmacies across the globe. The organisation caters to government, semi-government institutions, missionary hospitals, public sector enterprises, etc. Apart from this. the Company operate manufacturing plant at Sihor-Gujarat, approved as per W.H.O (World Health Organisation) guidelines with current Good Manufacturing Practices (GMP) requirements. In addition, it has a Research & Development unit duly approved by the Ministry of Science & Technology, Government of India. Hence, the Company has strong manufacturing facilities to cater to domestic and international market.The purpose of the Company is to serve those in need of quality healthcare by bringing revolutionary, life-changing therapeutic solutions that are accessible to all. Way back in the 20th century, a visionary in the field of healthcare and philanthropic work - Shri Nandlal Mulji Bhuta laid the foundation for several groups of companies. Continuing the legacy of Shri Nandlal Mulji Bhuta, his sons Mr. Uttam N. Bhuta and Mr. Hemendra N. Bhuta founded the Company.In 2021-22, the Company launched a new OTC division ~ Jenburkt Wellness towards better physical and mental health. The first brand launched was Zixa Strong, natural, pain relief product. Further, it launched Nervijen D3 tablets in 2022-23.Nervijen D3 tablets became the first brand in 2025 to reach a revenue target exceeding during the year.
Chairman & Managing Director
Ashish U Bhuta
Registered office Nirmala Apartment P B No 37396, 93 Jayprakash Road Andheri(W), Mumbai, Maharashtra, 400058
FAX :91-22-66943121/67603603
Background
Incorporation Year 1985
Face Value ₹10.00
Market Lot 1
FAQs on Jenburkt Pharmaceuticals Ltd
How to buy Jenburkt Pharmaceuticals Ltd shares on NSE?
To buy Jenburkt Pharmaceuticals Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the Jenburkt Pharmaceuticals Ltd share price today?
The Jenburkt Pharmaceuticals Ltd share price on NSE is ₹1073.75 today.
What is the market cap of Jenburkt Pharmaceuticals Ltd on NSE?
The company has a market capitalization of ₹473.88.
What is the PE & PB ratio of Jenburkt Pharmaceuticals Ltd?
PE is N/A and PB is 2.725.
What is the 52 Week High and Low of Jenburkt Pharmaceuticals Ltd shares?
Jenburkt Pharmaceuticals Ltd stock price high: ₹1410 Jenburkt Pharmaceuticals Ltd stock price low: ₹936.70.